(2S,4aS,6aS,7R,9R,10aR,10bS)-2-(furan-3-yl)-9-hydroxy-10b-methyl-4,6-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylic acid

Catalog No. :
ACQOEO859
CAS No. :
1236285-87-2
Molecular Formula :
C19H22O7
Molecular Weight :
362.38

IUPAC Name:(2S,4aS,6aS,7R,9R,10aR,10bS)-2-(furan-3-yl)-9-hydroxy-10b-methyl-4,6-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylic acid

(2S,4aS,6aS,7R,9R,10aR,10bS)-2-(furan-3-yl)-9-hydroxy-10b-methyl-4,6-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,4aS,6aS,7R,9R,10aR,10bS)-2-(furan-3-yl)-9-hydroxy-10b-methyl-4,6-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylic acid
IUPAC Name(2S,4aS,6aS,7R,9R,10aR,10bS)-2-(furan-3-yl)-9-hydroxy-10b-methyl-4,6-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylic acid
MDL No.MFCD28100626
Molecular FormulaC19H22O7
Molecular Weight362.38
SMILESC[C@@]12C[C@@H](C3=COC=C3)OC(=O)[C@H]1CC(=O)[C@H]1[C@H]2C[C@@H](O)C[C@H]1C(=O)O
InChI KeyPESWLPIIHLYDJT-OXIVVSFQSA-N
SynonymDiosbulbin L;(2S,4aS,6aS,7R,9R,10aR,10bS)-2-(3-Furanyl)dodecahydro-9-hydroxy-10b-methyl-4,6-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid;2H-Naphtho[2,1-c]pyran-7-carboxylic acid, 2-(3-furanyl)dodecahydro-9-hydroxy-10b-methyl-4,6-dioxo-, (2S,4aS,6aS,7R,9R,10aR,10bS)-
CAS No.1236285-87-2

Synthetic Route by SureRoute

1. ACQOEO859 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQOEO859 route product structure diagram
    ACQOEO8591236285-87-2
Inquiry

2. ACQOEO859 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQOEO859 route product structure diagram
    ACQOEO8591236285-87-2
Inquiry

Comments (0)